Title:
遺伝子改変Ｔ細胞を標的化するＣＤ１９を使用するＢ細胞悪性病変の同種細胞療法
Document Type and Number:
Japanese Patent JP2022531185
Kind Code:
A
Abstract:
Ｂ細胞悪性病変を治療するのに使用される、ＣＤ１９に特異的なキメラ抗原受容体（ＣＡＲ）を発現し、且つ破壊されたＴＲＡＣ遺伝子、破壊されたＢ２Ｍ遺伝子又は両方を含む、遺伝子改変された免疫細胞（例えば、Ｔ細胞）の集団。
Inventors:
Mark Benton
Tony Ho
Demetrius Karaizidis
Eberina Morawa
Jonathan Alexander Terret
Tony Ho
Demetrius Karaizidis
Eberina Morawa
Jonathan Alexander Terret
Application Number:
JP2021564281A
Publication Date:
July 06, 2022
Filing Date:
April 30, 2020
Export Citation:
Assignee:
Crisper Therapeutics Acchen Gezel Shaft
International Classes:
A61K35/17; A61K31/675; A61K31/7076; A61P7/00; A61P35/00; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Aoki Atsushi
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Tatsunori Ikeda
Junji Shibata
Shinji Mihashi
Youichi Watanabe
Nakajima Masaru
Tatsunori Ikeda
Junji Shibata
Previous Patent: Cancer treatment
Next Patent: Information processing methods, devices, electronic devices, storage media and programs
Next Patent: Information processing methods, devices, electronic devices, storage media and programs